Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood tests track lung Cancer's resistance to drugs

NCT ID NCT07475637

Summary

This study looked back at medical records to see how well a simple blood test could detect when lung cancer stops responding to certain drugs. Researchers analyzed data from 70 patients in Tunisia with advanced lung cancer who had developed resistance to their initial treatments. The goal was to understand if repeated blood tests could help guide future treatment decisions by spotting a specific genetic change linked to drug resistance.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Pathology Department, Charles Nicolle Hospital of Tunis

    Tunis, 1007, Tunisia

Conditions

Explore the condition pages connected to this study.